Literature DB >> 28938506

[Central Aortic Blood Pressure: Important Parameter in Diagnosis and Therapy].

Martin Middeke.   

Abstract

In recent years great emphasis has been placed on the role of central aortic blood pressure as measured non invasively using pulse wave analysis in pathophysiology of cardiovascular diseases and clinical aspects of hypertension. The difference of blood pressure between the central aorta and the brachial artery (amplification) is not constant but varies according to physiological, pathological and pharmacological mechanisms. Central aortic blood pressure is more strongly related to cardiovascular organ damages than does brachial pressure. Several antihypertensive drugs have different effects on aortic blood pressure as compared with brachial pressure. Central aortic blood pressure emerges superior to brachial pressure as target blood pressure in antihypertensive treatment. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28938506     DOI: 10.1055/s-0043-113212

Source DB:  PubMed          Journal:  Dtsch Med Wochenschr        ISSN: 0012-0472            Impact factor:   0.628


  4 in total

Review 1.  [Antihypertensive therapy in the elderly].

Authors:  J Schrader; B Schrader
Journal:  Herz       Date:  2018-05       Impact factor: 1.443

2.  [Personalized treatment concepts for arterial hypertension].

Authors:  Katharina Lechner; Heribert Schunkert
Journal:  Herz       Date:  2021-02       Impact factor: 1.443

3.  A Game-Based Approach to Lower Blood Pressure? Comparing Acute Hemodynamic Responses to Endurance Exercise and Exergaming: A Randomized Crossover Trial.

Authors:  Eva Kircher; Sascha Ketelhut; Kerstin Ketelhut; Lisa Röglin; Kuno Hottenrott; Anna Lisa Martin-Niedecken; Reinhard G Ketelhut
Journal:  Int J Environ Res Public Health       Date:  2022-01-26       Impact factor: 3.390

4.  Comparing the associations of clinic vs. ambulatory blood pressure with subclinical organ damage in young healthy adults: the African-PREDICT study.

Authors:  Dimoné Botha; Yolandi Breet; Aletta E Schutte
Journal:  Hypertens Res       Date:  2021-02-09       Impact factor: 3.872

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.